CARDIFF ONCOLOGY INC
CRDF · NASDAQ
Updated at 2026-10-14 09:20:46
- Today's High
- $1.04
- Today’s Low
- $1.00
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $1.08
- Previous Close
- $1.04
- Volume
- 378.93K
- Market Cap
- $80.9M
- P/E Ratio
- --
- EPS
- $-0.59
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 11055 FLINTKOTE AVENUE, SAN DIEGO, CA, UNITED STATES, 92121
- Country
- US
- Listing Date
- 2004-07-27
- Fiscal Year End
- December
- Shares Outstanding
- 77.8M
- CIK
- 0001213037
- Website
- cardiffoncology.com
Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops drugs for the treatment of cancer. The company is headquartered in San Diego, California.
Financial Metrics
Revenue
2026-06-30
$104K
2026-03-31
$41K
2025-12-31
$243K
2025-09-30
$120K
Operating Expenses
2026-06-30
$9.71M
2026-03-31
$12.89M
2025-12-31
$8.07M
2025-09-30
$12.09M
Net Income
2026-06-30
-$9.23M
2026-03-31
-$12.34M
2025-12-31
-$7.21M
2025-09-30
-$11.25M
Net Profit Margin
2026-06-30
-8.87K%
2026-03-31
-30.1K%
2025-12-31
-2.96K%
2025-09-30
-9.38K%
Earnings Per Share
2026-06-30
$-0.14
2026-03-31
$-0.18
2025-12-31
$-0.11
2025-09-30
$-0.17
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$9.01M
2026-03-31
-$12.12M
2025-12-31
-$6.99M
2025-09-30
-$10.76M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $104K | $41K | $243K | $120K |
| Operating Expenses | $9.71M | $12.89M | $8.07M | $12.09M |
| Net Income | -$9.23M | -$12.34M | -$7.21M | -$11.25M |
| Net Profit Margin | -8.87K% | -30.1K% | -2.96K% | -9.38K% |
| Earnings Per Share | $-0.14 | $-0.18 | $-0.11 | $-0.17 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$9.01M | -$12.12M | -$6.99M | -$10.76M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.